Evidence map›Paper›PMID 30171080›Full record

ArticleScience immunology2018

Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Samuel J Balin, Matteo Pellegrini, Eynav Klechevsky, Sohui T Won, David I Weiss, Aaron W Choi, Joshua Hakimian, Jing Lu, Maria Teresa Ochoa, Barry R Bloom and 3 more

Abstract read
In one paragraph

Article in Science immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Th17-driven CD8Cell death & disease · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. CD226 identifies effector CD8Cell reports · 2025
    Article
  10. Cytotoxic T Cells: Kill, Memorize, and Mask to Maintain Immune Homeostasis.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Vγ9Vδ2 T cells expanded with vitamin C combined with HMBPPFrontiers in cellular and infection microbiology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Samuel J BalinDivision of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0002-7646-1319
Matteo PellegriniMolecular Cell and Developmental Biology at UCLA, Los Angeles, CA 90095, USA.ORCID 0000-0001-9355-9564
Eynav KlechevskyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63108, USA.ORCID 0000-0001-6121-1571
Sohui T WonDepartment of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
David I WeissMolecular Biology Interdepartmental Graduate Program, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.ORCID 0000-0002-2068-7036
Aaron W ChoiDepartment of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Joshua HakimianDepartment of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Jing LuMolecular Cell and Developmental Biology at UCLA, Los Angeles, CA 90095, USA.
Maria Teresa OchoaDepartment of Dermatology, University of Southern California School of Medicine, Los Angeles, CA 90033, USA.ORCID 0000-0001-6550-5008
Barry R BloomHarvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Lewis L LanierDepartment of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0003-1308-3952
Steffen StengerInstitute for Medical Microbiology and Hygiene, University Hospital Ulm, Ulm, Germany.
Robert L ModlinDivision of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. rmodlin@mednet.ucla.edu.ORCID 0000-0003-4720-031X
University of California, Los Angeles · USHarvard University · USParker Institute for Cancer Immunotherapy · USUniversity Hospital Ulm · DEUniversity of Southern California · USWashington University in St. Louis · US

Funding

Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7M
TCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1990 to 2025
$10.4M
Vitamin D Metabolism in LeprosyP50AR063020 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PELLEGRINI, MATTEO · 2012 to 2016
$7.8M
NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
Anti-TB sterilizing immunity in immune and HIV+ individualsR01HL129887 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHEN, ZHENG W · 2015 to 2018
$2.1M
Role of Vitamin D Prohormone 25-OHD in the Immune Response to TuberculosisR01HL119068 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIU, PHILIP T., MODLIN, ROBERT L · 2014 to 2017
$1.5M
Tricytotoxic T cells protect against intracellular infection in human skinK08AR074552 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BALIN, SAMUEL JACKSON · 2019 to 2020
$256k
NHLBI NIH HHS R01 HL119068NHLBI NIH HHS R01 HL129887NIAID NIH HHS R01 AI022553NIAID NIH HHS R01 AI068129NIAMS NIH HHS K08 AR074552NIAMS NIH HHS P50 AR063020NIAMS NIH HHS R01 AR040312
6 · The paper itself

Abstract

Human CD8

Indexed as

Antigens, Differentiation, T-LymphocyteCytokinesGranzymesHumansLeprosyMycobacterium lepraemuriumPerforinReceptors, Natural Killer CellT-Lymphocytes, CytotoxicAntigens, Differentiation, T-LymphocyteCytokinesGNLY protein, humanGranzymesGZMB protein, humanPerforinReceptors, Natural Killer Cell

Identifiers

PMID30171080
PMCPMC6431239
OpenAlexW2889082173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.